Cargando…

Teleneuropsychology for vascular cognitive impairment: Which tools do we have?

The halt of clinical activities imposed during the COVID-19 pandemic forced clinicians to find alternative strategies to provide continuity of care and services, and led to a renewed interest in use of teleneuropsychology (TNP) to remotely assess patients. Recent TNP guidelines recommend maximizing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salvadori, Emilia, Pantoni, Leonardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299844/ https://www.ncbi.nlm.nih.gov/pubmed/37457663 http://dx.doi.org/10.1016/j.cccb.2023.100173

Ejemplares similares

Effectiveness of cognitive rehabilitation on mild cognitive impairment using teleneuropsychology
por: Canyazo, Carlos Martínez, et al.
Publicado: (2023)

Prediction of post-stroke cognitive impairment by Montreal Cognitive Assessment (MoCA) performances in acute stroke: comparison of three normative datasets
por: Salvadori, Emilia, et al.
Publicado: (2022)

Effect of Attention Training in Mild Cognitive Impairment Patients with Subcortical Vascular Changes: The RehAtt Study
por: Pantoni, Leonardo, et al.
Publicado: (2017)

A Teleneuropsychology Protocol for the Cognitive Assessment of Older Adults During COVID-19
por: Kitaigorodsky, Marcela, et al.
Publicado: (2021)

Relevance of brain lesion location for cognition in vascular mild cognitive impairment
por: Giorgio, Antonio, et al.
Publicado: (2019)

Teleneuropsychology: normative data for the assessment of memory in online settings
por: Rizzi, Ezia, et al.
Publicado: (2022)

Cancer, cognition, and COVID: delivering direct-to-home teleneuropsychology services to neuro-oncology patients
por: Gardner, Melissa M, et al.
Publicado: (2021)

Teleneuropsychology in the time of COVID-19: The experience of The Australian Epilepsy Project
por: Tailby, Chris, et al.
Publicado: (2020)

From Face-to-Face to Home-to-Home: Validity of a Teleneuropsychological Battery
por: Alegret, Montserrat, et al.
Publicado: (2021)

Clinical utility of Phototest via teleneuropsychology in Chilean rural older adults
por: Caldichoury, Nicole, et al.
Publicado: (2022)

Fractal dimension of cerebral white matter: A consistent feature for prediction of the cognitive performance in patients with small vessel disease and mild cognitive impairment
por: Pantoni, Leonardo, et al.
Publicado: (2019)

The clinical profile of cerebral small vessel disease: Toward an evidence‐based identification of cognitive markers
por: Salvadori, Emilia, et al.
Publicado: (2022)

Outcome of patients older than 85 years hospitalized in a neurology unit
por: Querzola, Giacomo, et al.
Publicado: (2023)

Survey Findings About the Experiences, Challenges, and Practical Advice/Solutions Regarding Teleneuropsychological Assessment in Adults
por: Fox-Fuller, Joshua T, et al.
Publicado: (2021)

Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial
por: Salvadori, Emilia, et al.
Publicado: (2021)

Fractal dimension of the cortical gray matter outweighs other brain MRI features as a predictor of transition to dementia in patients with mild cognitive impairment and leukoaraiosis
por: Marzi, Chiara, et al.
Publicado: (2023)

Infectious diseases and cognition: do we have to worry?
por: Hernandez-Ruiz, Virgilio, et al.
Publicado: (2022)

Implementation of a Hybrid Teleneuropsychology Method to Assess Middle Aged and Older Adults During the COVID-19 Pandemic
por: Ceslis, Amelia, et al.
Publicado: (2022)

Neonatal pain assessment: Do we have the right tools?
por: Llerena, Amelia, et al.
Publicado: (2023)

Do We Have Measures to Reduce Post-operative Cognitive Dysfunction?
por: Valdelievre, Thaddee, et al.
Publicado: (2022)

Do We Have the Spark?
por: Rupel, Valentina Prevolnik, et al.
Publicado: (2022)

Fit for purpose: do we have the right tools to sustain NTD elimination?
por: Reimer, Lisa J, et al.
Publicado: (2015)

Rapidly progressive dementia and intractable diarrhea: a teaching case report and a systematic review of cognitive impairment in Whipple’s disease
por: Manini, Arianna, et al.
Publicado: (2022)

Candida Auris, An Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind?
por: Sabino, Raquel, et al.
Publicado: (2020)

Why Do We Have Fingerprints?
Publicado: (2009)

The mask (which we need so much is the one we would have needed)()()
por: Torres, L.M., et al.
Publicado: (2020)

Do We Have the Right to Challenge the Rules of Nature Using Science and Technology Tools?
por: Sadeghi, Mohammad Reza
Publicado: (2019)

Longitudinal changes in MoCA performances in patients with mild cognitive impairment and small vessel disease. Results from the VMCI-Tuscany Study
por: Salvadori, Emilia, et al.
Publicado: (2021)

Evaluating Stress during Pregnancy: Do We Have the Right Conceptions and the Correct Tools to Assess It?
por: González-Ochoa, Raquel, et al.
Publicado: (2018)

Risk and Determinants of Dementia in Patients with Mild Cognitive Impairment and Brain Subcortical Vascular Changes: A Study of Clinical, Neuroimaging, and Biological Markers—The VMCI-Tuscany Study: Rationale, Design, and Methodology
por: Poggesi, Anna, et al.
Publicado: (2012)

Pain in Colorectal Surgery: How Does It Occur and What Tools Do We Have for Treatment?
por: Ivascu, Robert, et al.
Publicado: (2023)

Tools to measure the psychological impact of the COVID-19 pandemic: What do we have in the platter?
por: Cortez, Pedro Afonso, et al.
Publicado: (2020)

‘We Have Guidelines, but We Can Also Be Artists’: Neurologists Discuss Prognostic Uncertainty, Cognitive Biases, and Scoring Tools
por: Tolsa, Luca, et al.
Publicado: (2022)

Do Epilepsy Patients with Cognitive Impairment Have Alzheimer’s Disease-like Brain Metabolism?
por: He, Michael, et al.
Publicado: (2023)

Vascular cognitive impairment
por: Suvarna, Alladi
Publicado: (2009)

Drugs for malaria elimination: what do we have now and what do we need?
por: Shanks, Dennis
Publicado: (2014)

Treatment of vascular risk factors in patients with a diagnosis of Alzheimer’s disease: a systematic review
por: Valenti, Raffaella, et al.
Publicado: (2014)

Human preleukaemia: do we have a model?
por: Jacobs, A.
Publicado: (1987)

Premature ejaculation: do we have effective therapy?
por: Serefoglu, Ege Can, et al.
Publicado: (2013)

Presbycusis: do we have a third ear?()
por: Reis, Luis Roque, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r37vlju1430c22dcl8p7d4hcmo